Catalysts for Lupin Ltd
146 tracked
Apr 28, 2026
constraining patent expiry europe
Lupin Ltd — (dolutegravir + lamivudine + tenofovir disoproxil fumarate) (Constraining Patent Expiry (Europe))
(dolutegravir + lamivudine + tenofovir disoproxil fumarate)
→
Apr 15, 2026
approval
GLYCEROL PHENYLBUTYRATE — FDA approval
Lupin Ltd
→
Apr 6, 2026
approval
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approval
DAPAGLIFLOZIN
→
Apr 6, 2026
approval
DAPAGLIFLOZIN — FDA approval
DAPAGLIFLOZIN
→
Feb 23, 2026
approval
PREGABALIN — FDA approval
PREGABALIN
→
Feb 23, 2026
approval
PREGABALIN — FDA approval
PREGABALIN
→
Feb 23, 2026
approval
BRIVARACETAM — FDA approval
BRIVARACETAM
→
Jan 28, 2026
approval
DAYSEE (ETHINYL ESTRADIOL) — FDA approval
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
→
Jan 23, 2026
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
naloxone hydrochloride
→
Jan 23, 2026
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
naloxone hydrochloride
→
Dec 29, 2025
approval
MIRABEGRON — FDA approval
mirabegron ER
→
Dec 23, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Dec 23, 2025
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
Lupin Ltd
→
Dec 22, 2025
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
Lupin Ltd
→
Dec 18, 2025
approval
VARENICLINE TARTRATE — FDA approval
VARENICLINE TARTRATE
→
Dec 15, 2025
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
Lupin Ltd
→
Dec 15, 2025
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
Lupin Ltd
→
Nov 28, 2025
approval
ARMLUPEG (PEGFILGRASTIM-UNNE) — FDA approval
ARMLUPEG
→
Nov 28, 2025
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Oct 24, 2025
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Oct 23, 2025
approval
QUINAPRIL HYDROCHLORIDE — FDA approval
Lupin Ltd
→
Oct 23, 2025
approval
QUINAPRIL HYDROCHLORIDE — FDA approval
Lupin Ltd
→
Oct 21, 2025
approval
CELECOXIB — FDA approval
Celebrex
→
Oct 21, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Oct 1, 2025
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Sep 30, 2025
approval
ZIPRASIDONE HYDROCHLORIDE — FDA approval
Lupin Ltd
→
Sep 25, 2025
approval
RIVAROXABAN — FDA approval
RIVAROXABAN
→
Aug 13, 2025
recall
AEQUITA PHARMACY recall (Cls II)
Lupin Ltd
→
Aug 13, 2025
recall
AEQUITA PHARMACY recall (Cls II)
Lupin Ltd
→
Aug 13, 2025
recall
AEQUITA PHARMACY recall (Cls II)
Lupin Ltd
→